St. Jude Medical STJ released solid second-quarter results, and the firm remains on track to meet full-year projections. On the whole, the performance across St. Jude’s product segments are pleasing, and many are particularly heartened to see stability in implantable cardioverter defibrillator sales. After two years of soft demand following a published study that suggested overuse of ICDs, domestic demand fell off and we saw … Continue reading STJ On Track to Hit Full Year Numbers